# Baerveldt 350 vs Ahmed ClearPath 250 for the Treatment of Glaucoma

> **NCT04542616** · NA · COMPLETED · sponsor: **State University of New York at Buffalo** · enrollment: 80 (actual)

## Conditions studied

- Glaucoma

## Interventions

- **DEVICE:** Baerveldt 350 vs. Ahmed ClearPath 250 tube shunt implantation

## Key facts

- **NCT ID:** NCT04542616
- **Lead sponsor:** State University of New York at Buffalo
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-13
- **Primary completion:** 2024-07-31
- **Final completion:** 2024-07-31
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04542616

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04542616, "Baerveldt 350 vs Ahmed ClearPath 250 for the Treatment of Glaucoma". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT04542616. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*